I3 BioMedical’s TrioMed Active Technology is based on the

naturally occurring Tri-iodide molecules.

The actual application of trio-iodide as an antimicrobial

harnesses the “Microbial Killing” efficiency in an Active

molecule that activates to eliminate microbes with no

toxic effects on humans.

I3 BioMedical’s molecular grafting manufacturing

technology-enhanced products are available across

Europe, Canada, Mexico, North Africa, and Japan and

geographically expanding.